ETS1 and neoplasm: Importantly, ETS1 overexpression significantly increased the rate of tumor growth (Figure 7E) and markedly reduced overall survival in tumor-bearing mice (Figure 7F), suggesting that ETS1 may promote immune evasion and tumor progression through suppression of anti-tumor T cell responses.